COVID-19 Implications for Biopharma Presentations June 25, 2020 Jonathan Kfoury Anne Dhulesia Ben Faircloth
Related Practice Life Sciences & Pharma This report highlights how biopharma executives should adapt to the evolving biopharma landscape in both the nearer and longer term. 01262022160113
Special Report Diagnostics, Tools and Personalized Medicine Chronic Disease Management: The Case for MedTech Health Services September 19, 2022
Executive Insights Biotech and Pharmaceuticals Shareholder Value Creation for First-Time Launchers: Two Decades of Learnings December 30, 2022
Executive Insights Biotech and Pharmaceuticals Building Clinical Trial Leadership in Biopharma October 5, 2022